Affiliation:
1. Bashkir State Medical University; G.G. Kuvatov Republican Clinical Hospital
2. G.G. Kuvatov Republican Clinical Hospital
Abstract
Rationale. Alveococcosis is a rare disease, its diagnosis and treatment depend on surgical techniques, equipment and clinical experience. The aim. To develop a diagnostic algorithm and compare the results of surgical treatment of patients with liver alveococcosis in different periods of time.Materials and methods. At the first stage, we carried out a retrospective analysis (1995–2007) of 33 patients with alveococcosis (a comparison group). At the second stage, a prospective clinical study (2008–2021) was performed on 39 patients (the main group). The number of patients was determined in accordance with the inclusion and exclusion criteria, and the study groups were comparable in age, sex, parasite localization (p > 0.05). For the names of operations, the WHO classification of alveococcosis was used.Results. In the main group, there is an increase in the applicability of: enzyme immunoassay; ultrasound and computed tomography; biopsy. Complications decreased by 2.7 times from 54.6 % in the comparison group to 20.6 % in the main group (χ2 = 8.97; df = 1; p = 0.003). The average duration of operations, as well as the average volume of blood loss in the comparison group and the main group were, respectively: with atypical resection – 220.4 and 180.2 min (p = 0.003), 640.1 and 480.0 ml (p = 0.005); with anatomical resection – 296.2 and 247.2 min (p = 0.002), 1450.2 and 1150.3 ml (p = 0.018); with cytoreductive resection – 230.2 and 200.1 min (p = 0.004), 860.3 and 670.4 ml (p = 0.001). There were 13 (39 %) cytoreductive resections in the comparison group, and 3 (8 %) in the main group (χ2 = 4.74; df = 1; p = 0.029).Conclusion. Timely diagnosis of alveococcosis leads to an increase in the number of radical resections, and modern surgical technologies and equipment can reduce the time of surgery, blood loss and the number of complications.
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology
Reference22 articles.
1. Panteleev V, Nartaylakov M, Mustafin A, Abdeev R, Salimgareyev I, Samorodov A, et al. Surgical treatment of liver echinococcosis and alveococcosis. Le Infezion in Medicina (Italian). 2019; 27(4): 422-428.
2. Panteleev VS, Nartaylakov MA, Salimgareev IZ, Petrov AS. Alveolar disease of the liver: Classification and surgical interventions. Creative Surgery and Oncology. 2022; 12(3): 181-186. (In Russ.). doi: 10.24060/2076-3093-2022-12-3-181-186
3. Zagainov VE, Porshennikov IA, Kiselev NM, Naydenov EV, Pavlik VN, Voskanyan SE. New classification of alveolar echinococcosis of the liver as a base of new surgical strategy. A multicenter study. Annals of HPB Surgery. 2020; 25(4): 20-32. (In Russ.).
4. Yang C, He J, Yang X, Wang W. Surgical approaches for definitive treatment of hepatic alveolar echinococcosis: Results of a survey in 178 patients. Parasitology. 2019; 146(11): 1414-1420. doi: 10.1017/S0031182019000891
5. Baumann S, Shi R, Liu W, Bao H, Schmidberger J, Kratzer W, et al. Worldwide literature on epidemiology of human alveolar echinococcosis: A systematic review of research published in the twenty-first century. Infection. 2019; (18): 9-15. doi: 10.1007/s15010-019-01325-2